Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1964 4
1965 1
1987 1
2007 2
2015 1
2016 1
2020 1
2021 10
2022 12
2023 8
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

38 results

Results by year

Filters applied: . Clear all
Page 1
Early Postnatal Infection of Neonates Born to Mothers Infected by SARS-CoV-2 Omicron Variant.
Pietrasanta C, Ronchi A, Agosti M, Mangili G, Sinelli M, Ghirardello S, Barachetti R, Crimi R, Fasolato V, Martinelli S, Bellan C, Crippa B, Artieri G, Perniciaro S, Saruggia M, Ventura ML, Garofoli F, Pagliotta C, Uceda Renteria SC, Piralla A, Bergami F, Morandi G, Proto A, Pontiggia F, Risso FM, Bossi A, Ferrari S, Cavalleri V, Servi P, Castiglione A, Spada E, Ceriotti F, Baldanti F, Mosca F, Pugni L. Pietrasanta C, et al. Among authors: bergami f. Pediatrics. 2023 Nov 1;152(5):e2023062702. doi: 10.1542/peds.2023-062702. Pediatrics. 2023. PMID: 37830167
Human Cytomegalovirus (HCMV) - specific T-cell response after letermovir prophylaxis is predictive for subsequent HCMV reactivation in haematopoietic stem cell transplant recipients.
Zavaglio F, Vitello D, Bergami F, Arena F, Borsani O, Colombo AA, Caldera D, Lilleri D, Cassaniti I, Bernasconi P, Baldanti F. Zavaglio F, et al. Among authors: bergami f. J Clin Virol. 2023 Aug;165:105519. doi: 10.1016/j.jcv.2023.105519. Epub 2023 Jun 10. J Clin Virol. 2023. PMID: 37321150
SARS-CoV-2 infection risk is higher in vaccinated patients with inflammatory autoimmune diseases or liver transplantation treated with mycophenolate due to an impaired antiviral immune response: results of the extended follow up of the RIVALSA prospective cohort.
Rizzi M, Tonello S, Brinno C, Zecca E, Matino E, Cittone M, Rizzi E, Casciaro GF, D'Onghia D, Colangelo D, Minisini R, Bellan M, Castello LM, Chiocchetti A, Pirisi M, Rigamonti C, Lilleri D, Zavaglio F, Bergami F, Sola D, Sainaghi PP. Rizzi M, et al. Among authors: bergami f. Front Immunol. 2023 Jul 20;14:1185278. doi: 10.3389/fimmu.2023.1185278. eCollection 2023. Front Immunol. 2023. PMID: 37545528 Free PMC article.
Immunity to SARS-CoV-2 up to 15 months after infection.
Marcotte H, Piralla A, Zuo F, Du L, Cassaniti I, Wan H, Kumagai-Braesh M, Andréll J, Percivalle E, Sammartino JC, Wang Y, Vlachiotis S, Attevall J, Bergami F, Ferrari A, Colaneri M, Vecchia M, Sambo M, Zuccaro V, Asperges E, Bruno R, Oggionni T, Meloni F, Abolhassani H, Bertoglio F, Schubert M, Calzolai L, Varani L, Hust M, Xue Y, Hammarström L, Baldanti F, Pan-Hammarström Q. Marcotte H, et al. Among authors: bergami f. iScience. 2022 Feb 18;25(2):103743. doi: 10.1016/j.isci.2022.103743. Epub 2022 Jan 7. iScience. 2022. PMID: 35018336 Free PMC article.
Vaccination for herpes zoster in patients with solid tumors: a position paper on the behalf of the Associazione Italiana di Oncologia Medica (AIOM).
Pedrazzoli P, Lasagna A, Cassaniti I, Ferrari A, Bergami F, Silvestris N, Sapuppo E, Di Maio M, Cinieri S, Baldanti F. Pedrazzoli P, et al. Among authors: bergami f. ESMO Open. 2022 Aug;7(4):100548. doi: 10.1016/j.esmoop.2022.100548. Epub 2022 Jul 16. ESMO Open. 2022. PMID: 35853350 Free PMC article. Review.
The immunogenicity and the safety of the adjuvanted glycoprotein E (gE)-based recombinant vaccine against herpes zoster (RZV) in cancer patients during immunotherapy.
Lasagna A, Mele D, Bergami F, Alaimo D, Dauccia C, Alessio N, Comolli G, Pasi F, Muzzi A, Novelli V, Baldanti F, Pedrazzoli P, Cassaniti I. Lasagna A, et al. Among authors: bergami f. Hum Vaccin Immunother. 2023 Dec 15;19(3):2288282. doi: 10.1080/21645515.2023.2288282. Epub 2023 Dec 1. Hum Vaccin Immunother. 2023. PMID: 38037900 Free PMC article.
An overview of SARS-CoV-2 variants circulating in the 2020-2022 period in Lombardy.
Giardina F, Ferrari G, Zavaglio F, Paolucci S, Rovida F, Campanini G, Pellegrinelli L, Galli C, Pariani E, Bergami F, Nava A, Matarazzo E, Renica S, Fanti D, Cento V, Alteri C, Scaglione F, Vismara C, Perno CF, Piralla A, Baldanti F. Giardina F, et al. Among authors: bergami f. Diagn Microbiol Infect Dis. 2023 Dec;107(4):116070. doi: 10.1016/j.diagmicrobio.2023.116070. Epub 2023 Aug 26. Diagn Microbiol Infect Dis. 2023. PMID: 37714081
Heterologous immunization with inactivated vaccine followed by mRNA-booster elicits strong immunity against SARS-CoV-2 Omicron variant.
Zuo F, Abolhassani H, Du L, Piralla A, Bertoglio F, de Campos-Mata L, Wan H, Schubert M, Cassaniti I, Wang Y, Sammartino JC, Sun R, Vlachiotis S, Bergami F, Kumagai-Braesch M, Andréll J, Zhang Z, Xue Y, Wenzel EV, Calzolai L, Varani L, Rezaei N, Chavoshzadeh Z, Baldanti F, Hust M, Hammarström L, Marcotte H, Pan-Hammarström Q. Zuo F, et al. Among authors: bergami f. Nat Commun. 2022 May 13;13(1):2670. doi: 10.1038/s41467-022-30340-5. Nat Commun. 2022. PMID: 35562366 Free PMC article.
Impact of immunosuppressive treatment on the immunogenicity of mRNA COVID-19 vaccine in vulnerable patients with giant cell arteritis.
Delvino P, Bartoletti A, Cassaniti I, Bergami F, Lilleri D, Baldanti F, Bozzalla Cassione E, Biglia A, Montecucco C, Monti S. Delvino P, et al. Among authors: bergami f. Rheumatology (Oxford). 2022 Feb 2;61(2):870-872. doi: 10.1093/rheumatology/keab776. Rheumatology (Oxford). 2022. PMID: 34664631 Free PMC article. No abstract available.
38 results